Sreekanth K. Chaguturu - 01 Apr 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role: EVP and Chief Medical Officer
Signature: /s/ Sreekanth K. Chaguturu
Issuer symbol: CVS
Transactions as of: 01 Apr 2023
Net transactions value: +$2,895,935
Form type: 4
Filing time: 04 Apr 2023, 16:24:55 UTC
Previous filing: 01 Mar 2023
Next filing: 14 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CVS	Common Stock	Tax liability	$137,771	-1,854	-22%	$74.31	6,428	01 Apr 2023	Direct	F1
holding	CVS	Common Stock (Restricted)						21,972	01 Apr 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVS	Stock Option	Award	$3,033,706	+40,825		$74.31	40,825	01 Apr 2023	Common Stock	40,825	$74.31	Direct	F6
holding	CVS	Stock Option						5,952	01 Apr 2023	Common Stock	5,952	$75.27	Direct	F2
holding	CVS	Stock Option						9,579	01 Apr 2023	Common Stock	9,579	$58.34	Direct	F3
holding	CVS	Stock Option						9,502	01 Apr 2023	Common Stock	9,502	$74.30	Direct	F4
holding	CVS	Stock Option						12,993	01 Apr 2023	Common Stock	12,993	$101.09	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.
F2	Option became exercisable in four equal annual installments, commencing 11/29/2020.
F3	Option became exercisable in four equal annual installments, commencing 4/1/2021.
F4	Option became exercisable in four equal annual installments, commencing 4/1/2022.
F5	Option became exercisable in four equal annual installments, commencing 4/1/2023.
F6	Option becomes exercisable in four equal annual installments, commencing 4/1/2024.